The results showed that IL20RB was overexpressed in tumor tissues and promoter methylation levels of IL20RB were downregulated in tumor tissues and the degree of decline became more obvious with the increase of stage and grade (p < 0.001, Fig. 5B-E). The gene discussed is IL20RB; the disease is neoplasm.